Equites Radar

HNGE · Hinge Health, Inc.

Health Information ServicesUnited StatesAnalyst view: Buy

$88.59

+0.37% last session

End-of-day data · close of 2026-09-11

Bullish4 bullish · 1 bearish technical signals
Consensus: Buy (1.56 from 15 analysts)
To mean target: +22.1%

Market cap

$7B

Enterprise value

$7B

Trailing P/E

10.8

Forward P/E

29.0

Dividend yield

Beta

Avg volume

2M

Employees

1K

Daily Change %

0.37%

5 Days Change

-4.45%

10 Days Change

-1.96%

30 Days Change

2.25%

60 Days Change

-1.93%

Month to Day Change

-1.96%

Year to Day Change

90.01%

Analyst Outlook

Consensus ratingBuy
Recommendation mean (1–5)1.56
Covering analysts15
Mean price target$107.73
Low price target$85.00
Upside to mean target+22.1%

Analyst estimates change daily — follow the shifts on the Estimate Trends page.

Technical Analysis

RSI (14)50.9
50-day MA$86.02
200-day MA$57.71
Price vs 50-day MA+3.0%
Price vs 200-day MA+53.5%
MACD histogram-0.55
Volume vs 3-month avg0.9×
52w low $31.1752w high $92.85

Analyst sentiment over time — HNGE

Rec Mean (blue, left — higher = more bullish) vs. price targets (right).

Investment Bank Ratings as of 2026-09-08

Latest call per bank · past 12 months

RBC Capital

Outperform

$110

+24.6% vs price
▲ raised from $75.00Maintains · 2026-08-05

Wells Fargo

Overweight

$103

+16.7% vs price
▲ raised from $90.00Maintains · 2026-08-05

Barclays

Overweight

$100

+13.3% vs price
▲ raised from $97.00Maintains · 2026-08-05

Morgan Stanley

Overweight

$108

+22.4% vs price
▲ raised from $72.00Maintains · 2026-07-13

Recent rating actions

DateFirmActionRatingPrice target
2026-09-08StifelMaintainsBuy$96.00 $115
2026-08-11Truist SecuritiesMaintainsBuy$85.00 $112
2026-08-05RBC CapitalMaintainsOutperform$75.00 $110
2026-08-05CitizensMaintainsMarket Outperform$96.00 $107
2026-08-05Wells FargoMaintainsOverweight$90.00 $103
2026-08-05Evercore ISI GroupMaintainsOutperform$100 $105
2026-08-05BarclaysMaintainsOverweight$97.00 $100
2026-08-05NeedhamMaintainsBuy$76.00 $97.00

Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.

Signal Summary as of 2026-09-11

  • RSI (14): RSI is 51 — neutral momentum, neither overbought nor oversold.
  • Price vs 50-day MA: Trading 3.0% above the 50-day MA ($86.02).
  • Price vs 200-day MA: Trading 53.5% above the 200-day MA ($57.71).
  • MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
  • MACD (12,26,9): MACD histogram is negative (-0.55) — short-term momentum is fading.
  • 52-week range: Price is within 5% of the 52-week high ($92.85).

HNGE Price Chart

Loading chart for HNGE

Fundamentals

Revenue (TTM)$1.0B
EBITDA$0M
Free cash flow$0M
Operating cash flow$0M
Book value / share$4.29
Net Debt / EBITDA-4.0
WACC0.0%
Revenue growth53.00%
Earnings growth

About Hinge Health, Inc.

Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation. The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device. It primarily serves self-insured employers. The company was founded in 2012 and is headquartered in San Francisco, California.

More in Health Information Services

Screen HNGE against the full market on the Radar →

Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.